Metabolic syndrome and the risk of breast cancer;Sindrome metabolica e rischio di tumore mammario

Recenti Progressi in Medicina

Volumn 102, Issue 12, 2011, Pages 476-478

  Rosato, Valentina ^a   Bosetti, Cristina ^a   Talamini, Renato ^b   Levi, Fabio ^c   Negri, Eva ^a   Vecchia, Carlo La ^a,d,e  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSITY OF MILAN   (Italy)

^e INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

Breast cancer; Diabetes; Hyperlipidemia; Hypertension; Metabolic syndrome; Obesity

Indexed keywords

BREAST CANCER; CANCER RISK; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MULTICENTER STUDY; NOTE; POSTMENOPAUSE; RISK FACTOR; SWITZERLAND;

BREAST NEOPLASMS; FEMALE; HUMANS; METABOLIC SYNDROME X; RISK;

EID: 84855644436     PISSN: 00341193     EISSN: 20381840     Source Type: Journal    
DOI: None     Document Type: Note

References (24)

1. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5.
2. Pelucchi C, Negri E, Talamini R, et al. Metabolic syndrome is associated with colorectal cancer in men. Eur J Cancer 2010; 46: 1866-72.
3. Inoue M, Noda M, Kurahashi N, et al. Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur J Cancer Prev 2009; 18: 240-7.
4. Rosato V, Zucchetto A, Bosetti C, et al. Metabolic syndrome and endometrial cancer risk. Ann Oncol 2011; 22: 884-9.
5. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 2007; 86: s823-35.
6. Vona-Davis L, Howard-McNatt M, Rose DP. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 2007; 8: 395-408. (Pubitemid 47283945)
7. Russo A, Autelitano M, Bisanti L. Metabolic syndrome and cancer risk. Eur J Cancer 2008; 44: 293-7.
8. Porto LA, Lora KJ, Soares JC, Costa LO. Metabolic syndrome is an independent risk factor for breast cancer. Arch Gynecol Obstet 2011; 284: 1271-76.
9. Agnoli C, Berrino F, Abagnato CA, et al. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis 2010; 20: 41-8.
10. Bjorge T, Lukanova A, Jonsson H, et al. Metabolic syndrome and breast cancer in the Me-Can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010; 19: 1737-45.
11. Kabat GC, Kim M, Chlebowski RT, et al. A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 2046-53.
12. Capasso I, Esposito E, Pentimalli F, et al. Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience. Cancer Biol Ther 2010; 10: 1240-3.
13. Rosato V, Bosetti C, Talamini R, et al. Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol 2011 Mar 23 [Epub ahead of print].
14. Shen W, Punyanitya M, Silva AM, et al. Sexual dimorphism of adipose tissue distribution across the lifespan: a cross-sectional whole-body magnetic resonance imaging study. Nutr Metab (Lond) 2009; 6: 17.
15. Largent JA, McEligot AJ, Ziogas A, et al. Hypertension, diuretics and breast cancer risk. J Hum Hypertens 2006; 20: 727-32. (Pubitemid 44430670)
16. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, La Vecchia C. Hypertension and hormonerelated neoplasms in women. Hypertension 1999; 34: 320-5.
17. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med 2005; 165: 2264-71. (Pubitemid 41549923)
18. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 2004; 96: 1152-60. (Pubitemid 39207051)
19. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter? Circulation 2007; 115: 1806-10; discussion 11.
20. Beaser RS, Levy P. Metabolic syndrome: a work in progress, but a useful construct. Circulation 2007; 115: 1812-8; discussion 8.
21. La Vecchia C, Negri E, Franceschi S, et al. Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer 1997; 75: 441-4. (Pubitemid 27051064)
22. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95: 1218-26. (Pubitemid 37069552)
23. Campagnoli C, Pasanini P, Peris C, Berrino F. Insuline-like growth factor I and breast cancer: epidemiological and clinical data. Breast cancer: prognosis, treatment and prevention. 2nd ed., 2008.
24. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol 2010; 40: 189-207.